Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: A cohort study in the Clinical Practice Research Datalink 2004-2014

BMJ Open

Volumn 7, Issue 2, 2017, Pages

  Mathur, Rohini ^a   Bhaskaran, Krishnan ^a   Edwards, Emma ^b   Lee, Helen ^b   Chaturvedi, Nishi ^c   Smeeth, Liam ^a   Douglas, Ian ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Royal National Institute of Blind People   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CLINICAL PRACTICE; COHORT ANALYSIS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; FOLLOW UP; GENDER; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREVALENCE; SCHOOL CHILD; SCREENING; UNITED KINGDOM; YOUNG ADULT; AGE DISTRIBUTION; FACTUAL DATABASE; HEALTH DISPARITY; METABOLISM; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX RATIO; SOCIOECONOMICS; VERY ELDERLY;

GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; COHORT STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GLYCATED HEMOGLOBIN A; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; UNITED KINGDOM; YOUNG ADULT;

EID: 85014225644     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-014444     Document Type: Article

References (56)

1. Diabetes UK. Diabetes in the UK 2010: Key statistics on diabetes. 2010. https://www.diabetes.org.uk/documents/reports/diabetes-in-the-uk-2010.pdf
2. Diabetes UK. Eyes (retinopathy). 2015. https://www.diabetes.org.uk/Guide-to-diabetes/Complications/Retinopathy/
3. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
4. Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes 1989;38:1203-6.
5. Harney F. Diabetic retinopathy. Medicine (Baltimore) 2006;34:95-8.
6. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;376:124-36.
7. Cappuccio FP, Barbato A, Kerry S. Hypertension, diabetes and cardiovascular risk in ethnic minorities in the UK. Br J Diabetes Vasc Dis 2003;3:286-93.
8. Bakker LE, Sleddering MA, Schoones JW, et al. Pathogenesis of type 2 diabetes in South Asians. Eur J Endocrinol 2013;169: R99-114.
9. Tillin T, Hughes AD, Whincup P, et al. Excess diabetes in ethnic minorities-incidence and predictors. Diabetologia 2011; Conference: 47th Annual Meeting of the European Association for the study of diabetes.
10. Agyemang C, Kunst AE, Bhopal R, et al. Diabetes prevalence in populations of South Asian Indian and African origins: a comparison of England and the Netherlands. Epidemiology 2011;22:563-7.
11. McKeigue PM, Shah B, Marmot MG, et al. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-6.
12. Bhopal RS. A four-stage model explaining the higher risk of type 2 diabetes mellitus in South Asians compared with European populations. Diabet Med 2013;30:35-42.
13. Tillin T, Hughes AD, Godsland IF, et al. Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall and Brent Revisited (SABRE) cohort. Diabetes Care 2013;36:383-93.
14. Davis TME. Ethnic diversity in type 2 diabetes. Diabet Med 2008;25 (Suppl 2):52-6.
15. Sivaprasad S, Gupta B, Crosby-Nwaobi R, et al. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol 2012;57:347-70.
16. Gupta R, Misra A. Epidemiology of microvascular complications of diabetes in South Asians and comparison with other ethnicities. J Diabetes 2016;8:470-82.
17. Haffner SM, Fong D, Stern MP, et al. Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes 1988;37:878-84.
18. Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. Jama 2010;304:649-56.
19. Kempen JH, O'Colmain BJ, Leske MC, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004;122:552-63.
20. Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Experiment Ophthalmol 2016;44:260-77.
21. Harris MI, Klein R, Cowie CC, et al. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes A U.S. population study. Diabetes Care 1998;21:1230-5.
22. Raymond NT, Varadhan L, Reynold DR, et al. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with White Europeans in the community: a cross-sectional study. Diabetes Care 2009;32:410-5.
23. Low L, Law JP, Hodson J, et al. Impact of socioeconomic deprivation on the development of diabetic retinopathy: a population-based, cross-sectional and longitudinal study over 12 years. BMJ Open 2015;5:e007290.
24. Lane M, Mathewson PA, Sharma HE, et al. Social deprivation as a risk factor for late presentation of proliferative diabetic retinopathy. Clin Ophthalmol 2015;9:347-52.
25. Harris M, Lead C, Warehouse V, et al. The NHS diabetic eye screening programme: new common pathway. The Royal College of Opthamologists Focus, Winter. 2012:5-6. https://www.rcophth.ac.uk/wp-content/uploads/2014/08/Focus-Winter-2012.pdf
26. Lindenmeyer A, Sturt JA, Hipwell A, et al. Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case study. Br J Gen Pract 2014;64:484-92.
27. Broadbent D. Diabetic retinopathy: fundamentals for primary care. Diabetes Prim Care 2013;12:201-10.
28. Kostev K, Rathmann W. Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: a database analysis. Diabetologia 2013;56:109-11.
29. Looker HC, Cromie D. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetes 2011;60:A183.
30. Thomas RL, Dunstan FD, Luzio SD, et al. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br J Ophthalmol 2015;99:64-8.
31. Younis N, Broadbent DM, Vora JP, et al. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003;361:195-200.
32. Leese GP, Boyle P, Feng Z, et al. Screening uptake in a well-established diabetic retinopathy screening program the role of geographical access and deprivation. Diabetes Care 2008;31:2131-5.
33. Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015;44:827-36.
34. Mathur R, Bhaskaran K, Chaturvedi N, et al. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Heal 2013;36:684-92.
35. Chisholm J. The Read clinical classification. BMJ 1990;300:1092.
36. Allen N, Sudlow C, Downey P, et al. UK Biobank: Current status and what it means for epidemiology. Heal Policy Technol 2012;1:123-6.
37. Mclennan D, Barnes H, Noble M, et al. The English indices of deprivation 2010-technical report. Soc Policy 2011. Published Online First: 2011.
38. Hull SA, Mathur R, Badrick E, et al. Recording ethnicity in primary care: assessing the methods and impact. Br J Gen Pract 2011;61: e290-4.
39. Office for National Statistics. Population estimates for UK, England and Wales, Scotland and Northern Ireland, mid-2014. 2015. http://www.ons.gov.uk/ons/publications/re-reference-tables.html edition=tcm%3A77-368259 (accessed 1 Nov 2015).
40. Delcourt C, Massin P, Rosilio M. Epidemiology of diabetic retinopathy: expected vs reported prevalence of cases in the French population. Diabetes Metab 2009;35:431-8.
41. Strutton R, Du Chemin A, Stratton IM, et al. System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation: table 1. BMJ Open 2016;6:e010952.
42. Gardunõ-Diaz SD, Khokhar S. Prevalence, risk factors and complications associated with type 2 diabetes in migrant South Asians. Diabetes Metab Res Rev 2012;28:6-24.
43. Gholap N, Davies M, Patel K, et al. Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes 2011;5:45-56.
44. Ivey SL, Mehta KM, Fyr CL, et al. Prevalence and correlates of cardiovascular risk factors in South Asians: population-based data from two California surveys. Ethn Dis 2006;16:886-93.
45. Beeching NJ, Gill GV. Deprivation and type 2 diabetes mellitus prevalence. Diabet Med 2000;17:813.
46. Sivaprasad S, Gupta B, Gulliford MC, et al. Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). PLoS ONE 2012;7: e32182.
47. Doran T, Fullwood C, Gravelle H, et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med 2006;355:375-84.
48. Khunti K, Gadsby R, Millett C, et al. Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for diabetes. Diabet Med 2007;24:1436-41.
49. Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010;69:4-14.
50. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010;60:e128-36.
51. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the general practice research database. Pharmacotherapy 2003;23:686-9.
52. Konig M, Lamos EM, Stein SA, et al. An insight into the recent diabetes trials: what is the best approach to prevent macrovascular and microvascular complications. Curr Diabetes Rev 2013;9:371-81.
53. Turner R, Matthews D, Neil A, et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998;317:703-13.
54. ONS. Total Population (UK) Mid-2014 Estimate. 2014. http://ons.gov. uk/ons/taxonomy/index.htmlnscl=Population (accessed 30 Jul 2015).
55. Public Health England. NHS Screening Programmes in England 2013/14. 2015. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/574717/Screening-in-England-2013-to-2014.pdf
56. Knight A, Lindfield R. The relationship between socio-economic status and access to eye health services in the UK: a systematic review. Public Health 2015;129:94-102.